date:Apr 24, 2013
25, is an essential step in our strategy to transform into a bio-based ingredients company, said Gerard Hoetmer, chief executive officer of CSM. Selling these businesses in one transaction, in accordance with our original intention, will lead to minimal disruption for the divested businesses and the continuing business. We have found in Rhone Capital a strong partner which supports existing management in its global growth ambition. Both parties are working toward a fast finalization and smooth